EC backs voluntary COVID-19 vaccine licensing

The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Ghana in licensing talks to manufacture AstraZeneca vaccine

27 April 2021 Ghana’s pharmaceutical industry has asked AstraZeneca about acquiring rights to produce its COVID vaccine locally, buoying the country’s inoculation efforts.

Big Pharma

CPI receives £5m from UK govt for 'vaccine library'

4 March 2021 UK innovation hub CPI has received a further £5 million investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19.

Big Pharma

EU concludes COVID-19 vaccine talks with Pfizer

10 September 2020 The European Commission has concluded exploratory talks with Pfizer and BioNTech to potentially supply 300 million doses of their investigational vaccine against COVID-19.

More features

AIPPI: Personalised medicine tests the limits in patent law

Ropes & Gray loses 21-attorney group to join rival on growth spree

How 'Boehringer' sets preliminary relief threshold for generics

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

EC backs voluntary COVID-19 vaccine licensing

More on this story

Editor's picks

Editor's picks

More features